Long‐term outcome of juvenile idiopathic arthritis following a placebo‐controlled trial: sustained benefits of early sulfasalazine treatment

OBJECTIVES: A previous 24‐week randomised trial demonstrated that sulfasalazine (SSZ) treatment was superior to placebo (PLAC) in suppressing disease activity in patients with oligo‐ and polyarticular onset juvenile idiopathic arthritis (JIA). The current study determines the long‐term outcome of th...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: van Rossum, Marion A J, van Soesbergen, Renée M, Boers, Maarten, Zwinderman, Aeilko H, Fiselier, Theo J W, Franssen, Marcel J A M, Cate, Rebecca ten, van Suijlekom‐Smit, Lisette W A, Wulffraat, Nico M, van Luijk, Wilma H J, Oostveen, Johanna C M, Kuis, Wietse, Dijkmans, Ben A C
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2007
Предметы:
Extended Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2111611/
https://ncbi.nlm.nih.gov/pubmed/17491099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.064717
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы